Safety and efficacy of pasireotide in dumping syndrome-results from a phase 2, multicentre study.

Tack JanJ AberleJ ArtsM LavilleJ-M OppertG BenderS BhoyrulT McLaughlinT YoshikawaA VellaJ ZhouV Q PassosP O'ConnellA P Van Beek

Published in: Alimentary pharmacology & therapeutics (2018)

These results suggest that pasireotide is a promising option in patients with dumping syndrome after bariatric or upper gastrointestinal cancer surgery.

Keyphrases

minimally invasive
case report
papillary thyroid
coronary artery bypass
weight loss
gastric bypass
percutaneous coronary intervention
atrial fibrillation